HOME >> BIOLOGY >> NEWS
New gene marker may identify need for intense AML therapy

COLUMBUS, Ohio Researchers here have discovered a new marker that might identify a serious form of acute myeloid leukemia (AML) in people who lack the signs that normally alert doctors that the patient needs intense therapy.

The study was led by researchers with The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. It focused on AML patients whose cancer cells show none of the chromosome alterations that help doctors determine the probable prognosis and the best potential treatment for many people with acute leukemia.

Specifically, the study examined the activity of a gene known as ETS-Related Gene (ERG) in AML cells from these patients.

The findings, published online in the Journal of Clinical Oncology, suggest that when AML cells show high ERG activity, it signals an aggressive form of cancer that requires intense therapy, such as a stem-cell transplant from a matched donor.

Importantly, the study also showed that effects of ERG activity on disease relapse and long-term survival are influenced by the activity levels of other genes.

Last, the study suggests that ERG plays an important role in AML development and could provide a new target for future AML therapy.

The findings come from a Cancer and Leukemia Group B (CALGB) study led by Clara D. Bloomfield, professor of internal medicine, the William G. Pace III Professor in Cancer Research, OSU Cancer Scholar and senior adviser to the OSU Cancer Program.

"This is another of only a few predictive molecular markers for adults with AML who have normal cytogenetics," says Bloomfield, who led the research that identified the first molecular marker for AML in this group of patients. Normal cytogenetics refers to cells with normal-looking chromosomes.

"If confirmed, our findings should improve survival in these patients and spare those who now receive more intense therapy but d
'"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University
14-Nov-2005


Page: 1 2 3

Related biology news :

1. Research aims to identify markers for menopausal women at risk for deadly blood clot
2. Contributing membership in the biomarkers consortium surges to 30 companies and nonprofits
3. Cell receptor may lead to new biomarker for pancreatic cancer
4. Researchers isolate new risk marker for overweight children
5. New tumor markers -- Spot the differences
6. Tumor vessels identified by unique molecular markers
7. Jaap Sinninghe Damst awarded the Vernadsky Medal for innovative use of biomarkers
8. Pancreatic cancer markers identified, may predict survival
9. Researchers identify key gene that may be a marker of breast cancer metastasis
10. Genes and biomarkers that allow doctors to choose the right therapy for the right patient
11. AACR, FDA and NCI announce cancer biomarkers collaborative at the AACR 2007 annual meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... August 14, 2019 , ... An upcoming episode of Advancements ... therapeutics are helping to promote normal immune function in order to prevent and ... about the DECODE.DESIGN.CURE™ technology platform, which rapidly develops microbiome therapeutics in order to ...
(Date:8/14/2019)... ... ... Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel Research in ... learn about two common imaging methods in NAFLD/NASH to aid with early disease diagnosis, ... disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided into simple ...
(Date:8/14/2019)... ... August 14, 2019 , ... Gateway Genomics , a ... announces inclusion in the 38th annual Inc. 500|5000 list of fastest growing ... qualify, companies must have been founded and generating revenue by March 31, 2015. Ranking ...
Breaking Biology News(10 mins):
(Date:8/23/2019)... ... August 22, 2019 , ... An ... and is scheduled to broadcast 4Q/2019. Check your local listings for more information. ... for generic drug delivery. Focusing on therapeutics for children and the elderly, viewers ...
(Date:8/14/2019)... STATE COLLEGE, Pa. (PRWEB) , ... August 13, ... ... leader in nuclear receptor and in vitro toxicology testing solutions, announced the appointment ... of healthcare industry experience to the Board. , Mark McLoughlin will lend his ...
(Date:8/8/2019)... ... August 08, 2019 , ... ... for sales and service organizations, today announced that the company’s Studio Intelligent Virtual ... the IVA market . Inference will officially accept the award at Frost & ...
(Date:8/6/2019)... ... 06, 2019 , ... The San Diego Biotechnology Network (SDBN) ... SDBN BUZZ podcast focused on connecting the region’s biotech community and discussing topics ... the region and attract external employers, investors, scientists, and others who wish to ...
Breaking Biology Technology:
Cached News: